About Us>Our team > Sameer Gupta, MD, MPH

Sameer Gupta, MD, MPH

Clinical Assistant Professor, Jefferson Medical College; Medical Oncologist, Bryn Mawr Hospital 

Highlights

featured_paragraph

Sameer Gupta, MD, MPH, is a medical oncologist at Bryn Mawr Hospital in Bryn Mawr, Pennsylvania, who has a specific interest in taking care of patients with breast cancer.

general_content

He has been involved in patient care, patient education, medical education, and advocacy for his patients over the last decade. He is part of Bryn Mawr Hospital’s multidisciplinary breast cancer center and supervises fellows specializing in breast cancer surgical oncology.

Prior to joining staff at Bryn Mawr Hospital, Dr. Gupta completed a medical oncology/hematology fellowship at Fox Chase Cancer Center in Philadelphia. He completed his internal medicine residency program from University of Buffalo and has a Master's in public health from the University of Alabama in Birmingham. He lives in Penn Valley, Pennsylvania with his wife (who is also an oncologist) and two daughters.

3_column_content

Experience & accolades

Expertise

  • Medical oncology
  • Hematology

Education

  • University of Alabama at Birmingham
    • Master’s in public health, health care organization and policy
  • Fox Chase Cancer Center/Temple University Hospital
    • Fellowship in hematology/oncology
  • State University of New York at Buffalo
    • Internship and residency in internal medicine
  • All India Institute of Medical Sciences, New Delhi, India
    • Residency in medical oncology
  • Malauna Azad Medical College, New Delhi, India
    • Bachelor of medicine
    • Bachelor of surgery

Experience

  • Bryn Mawr Hospital (2011-Present)
    • Medical oncologist
    • Instruction of Bryn Mawr Family Practice program residents
    • Education of Bryn Mawr Hospital breast surgical oncology fellows
    • Preceptor for medical student hematology/oncology rotation
    • Preceptor for family medicine resident hematology/oncology rotation
    • Preceptor for breast surgical fellow oncology rotation
    • Preceptor for Bryn Mawr College Pre-medical rotation

Awards & distinctions

  • Top Doctor, Hematology/Oncology, Philadelphia Magazine, 2017-2023
  • Top Doctor, Hematology/Oncology, Mainline Today Magazine, 2013-2023
  • NCCN Fellows Recognition Program, NCCN, 2009
  • Sanofi-Aventis Fellows travel grant recipient, ASH Annual Meeting, 2009
  • Dexter S. Levy House Staff Award for Excellence in Bedside Teaching, Internal Medicine Program of the State University of New York at Buffalo, 2008
  • Norman Chassin Award for Best Intern, Internal Medicine Program of the State University of New York at Buffalo, 2006
  • Academic Excellence Recognition, School of Public Health at the University of Alabama at Birmingham, 2005
  • Academic Excellence Award, International Scholars and Student Services, University of Alabama at Birmingham, 2005
  • DR Thapar Gold Medal of Excellence in Surgery, Maulana Azad Medical College, 2001
  • VP Chadha Memorial Medal for Excellence in Surgery, University of Delhi, 2001
  • Junior Science Talent Search Award, directorate of education, govt. of Delhi, 1995

Professional memberships & board positions

  • Medical Advisory Board, Living Beyond Breast Cancer 2024-present
  • American Society of Clinical Oncology, 2010-Present
  • Eastern Cooperative Oncology Group, 2011-present
  • American Association for Cancer Research, 2010-2011
  • American Society of Hematology, 2009-2010
  • American College of Physicians, 2005-2010

Publications

  • Ali, SA, Gupta, S, Sehgal, R, et al. Survival outcomes in pregnancy associated breast cancer: a retrospective case control study. Breast J. 2012
  • Gupta, S, Engstrom, PF, Cohen, SJ. Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors. Clinical Colorectal Cancer. 2011
  • Aggarwal, C, Gupta, S, Hahn, T, et al. Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogenic hematopoietic stem cell transplantation for lymphoid malignancies. Leukemia and Lymphoma. 2008
  • Gupta, S, Almyroudis, N, Battiwala, M, et al. Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogenic hematopoietic stem cell transplantation. Transplant Infectious Disease. 2007
  • Gupta, S., Silliman, C, Trump, DL. Docetaxel induced meibomian duct inflammation and blockage leading to chalazion formation. Prostate Cancer and Prostatic Diseases. 2007
contributions_carousel

Contributions

Targeted therapy for hormone receptor-positive breast cancer

10/14/24 | BY: Sameer Gupta, Pallav K. Mehta

Targeted therapies are treatments that target specific proteins or markers on or within cancer cells that help cancer cells grow. There are many different kinds of targeted therapy, including CDK 4/6 inhibitors.

Read More
 | 12 Min. Read |

Ribociclib

09/18/24 | BY: Sameer Gupta

Ribociclib (Kisqali), a targeted therapy, is the second CDK 4/6 inhibitor to be approved by the FDA. It targets two specific kinases, or enzymes, that help tumor cells grow and divide.

Read More
 | 6 Min. Read |

Molecular subtypes of breast cancer

03/12/24 | BY: Sameer Gupta

Molecular subtype is a term that describes how breast cancer cells behave based on their characteristics. This information may help you and your care team develop your treatment plan.

Read More
 | 6 Min. Read

Capivasertib

02/03/24 | BY: Sameer Gupta

Capivasertib (Truqap) is a targeted therapy used to treat hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancers that test positive for certain gene mutations

Read More
 | 9 Min. Read |

Abemaciclib

12/01/23 | BY: Sameer Gupta

Abemaciclib (Verzenio) is a targeted therapy approved by the Food and Drug Administration to treat hormone receptor-positive breast cancer.

Read More
 | 8 Min. Read |

Palbociclib

04/19/23 | BY: Sameer Gupta

Palbociclib (Ibrance), a targeted therapy, was the first CDK 4/6 inhibitor to be approved by the FDA. It targets two specific kinases, or enzymes, that help tumor cells grow and divide.

Read More
 | 5 Min. Read |

Circulating tumor DNA (ctDNA) tests

03/30/23 | BY: Sameer Gupta, Reshma L. Mahtani

Circulating tumor DNA, or ctDNA, tests analyze a blood sample to look for fragments of genetic information (DNA) shed by cancer cells into the bloodstream. Another term used for this testing is liquid biopsy.

Read More
 | 12 Min. Read |

Where breast cancer spreads

07/20/22 | BY: Sameer Gupta

If you have metastatic breast cancer, it means breast cancer cells spread away, or metastasized, from your breast tissue to other, distant areas of the body.

Read More
 | 11 Min. Read

Metastatic breast cancer side effects

03/09/22 | BY: Sameer Gupta

The side effects of metastatic breast cancer can develop due to various treatments. Learn more about how to manage side effects and improve your quality of life.

Read More
 | 28 Min. Read

Side effects

02/04/22 | BY: Sameer Gupta

Side effects are unwanted reactions to medical treatments and can be among the most upsetting parts of being treated for breast cancer. There are many things you can do to help prevent and manage side effects.

Read More
 | 8 Min. Read |